MedTrace Logo

Virtual Reality for Anxiety Relief in Infertile Women

NCT07020975 · Status: ENROLLING_BY_INVITATION · Phase: NA · Type: INTERVENTIONAL · Enrollment: 80

Last updated 2025-06-13

No results posted yet for this study

Summary

This study examines the impact of virtual reality (VR) applications on anxiety levels before and after embryo transfer procedures. The clinical trial will involve 80 participants, aged 18 to 50, who are receiving treatment at a healthcare facility in the Turkish Republic of Northern Cyprus (TRNC). The primary objective is to evaluate the effectiveness of VR as an intervention for reducing anxiety in individuals undergoing assisted reproductive treatments.

Conditions

  • Anxiety
  • Assisted Reproductive Treatments
  • Women
  • VR
  • Stress
  • Virtual Goggles
  • Infertility
  • Embryo Transfer

Interventions

DEVICE

VR Glasses

VR Glasses is used to help people be in a virtual reality other than their real life. What we use this for; to get away infertile women from her stressfull environment to another virtual reality before their embryo transfer.

Sponsors & Collaborators

  • Cyprus Aydin University

    lead OTHER

Principal Investigators

  • NAZLI CATAK, MSc

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
50 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2025-03-01
Primary Completion
2026-03-01
Completion
2026-03-01

Countries

  • Cyprus

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07020975 on ClinicalTrials.gov